NCT03663387View on ClinicalTrials.gov

PET Measures of CSF Clearance in Preclinical Alzheimer's Disease

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

July 30, 2018

Primary Completion Date

August 31, 2022

Study Completion Date

August 31, 2022

Conditions
Mild Cognitive Impairment
Trial Locations (1)

10021

Weill Cornell Medicine, New York

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Weill Medical College of Cornell University

OTHER

NCT03663387 - PET Measures of CSF Clearance in Preclinical Alzheimer's Disease | Biotech Hunter | Biotech Hunter